Cargando…

Rotavirus Vaccination of Infants Delayed and Limited within the National Immunization Programme in the Netherlands: An Opportunity Lost

In this study, we estimated the benefits of rotavirus vaccination for infants had the rotavirus vaccine been introduced in the Netherlands as of its market authorization in 2006. An age-structured, deterministic cohort model was developed to simulate different birth cohorts over a period of 15 years...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeevat, Florian, Dvortsin, Evgeni, Wondimu, Abrham, Wilschut, Jan C., Boersma, Cornelis, Postma, Maarten J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916749/ https://www.ncbi.nlm.nih.gov/pubmed/33579025 http://dx.doi.org/10.3390/vaccines9020144

Ejemplares similares

Factors associated with the uptake of newly introduced childhood vaccinations in Ethiopia: the cases of rotavirus and pneumococcal conjugate vaccines
por: Wondimu, Abrham, et al.
Publicado: (2019)

Reply to Anglemyer et al
por: Zeevat, Florian, et al.
Publicado: (2021)

Inequalities in Rotavirus Vaccine Uptake in Ethiopia: A Decomposition Analysis
por: Wondimu, Abrham, et al.
Publicado: (2020)

Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model
por: Rozenbaum, Mark H, et al.
Publicado: (2011)

An Updated Analysis of the Impact of HPV Vaccination Based on Long-term Effectiveness in the Netherlands
por: Luttjeboer, Jos, et al.
Publicado: (2023)

An update of “Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model”
por: Tu, Hong Anh T, et al.
Publicado: (2013)

Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands
por: Eijsink, Job F. H., et al.
Publicado: (2020)

Exploratory Analysis of the Economically Justifiable Price of a Hypothetical RSV Vaccine for Older Adults in the Netherlands and the United Kingdom
por: Zeevat, F, et al.
Publicado: (2021)

Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands: A systematic review
por: van Schoonhoven, Alexander V., et al.
Publicado: (2019)

Comparative Cost-Effectiveness of Drugs in Early versus Late Stages of Cancer; Review of the Literature and a Case Study in Breast Cancer
por: Dvortsin, Evgeni, et al.
Publicado: (2016)

Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands
por: Stevanović, J., et al.
Publicado: (2016)

PRS27 Incorporating Heterogeneity in Risk for Infection and Disease in Cost-Effectiveness of Preventative Strategies in Older Adults
por: Zeevat, F., et al.
Publicado: (2020)

Burden of early, advanced and metastatic breast cancer in The Netherlands
por: Vondeling, G. T., et al.
Publicado: (2018)

Lost Opportunities
Publicado: (1883)

Understanding the Improvement in Full Childhood Vaccination Coverage in Ethiopia Using Oaxaca–Blinder Decomposition Analysis
por: Wondimu, Abrham, et al.
Publicado: (2020)

Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands
por: Hagendijk, Marije E., et al.
Publicado: (2021)

Lost opportunities in HIV prevention: programmes miss places where exposures are highest
por: Sandøy, Ingvild F, et al.
Publicado: (2008)

Health Economics of Vaccines: From Current Practice to Future Perspectives
por: Boersma, Cornelis, et al.
Publicado: (2021)

The Cost-Effectiveness of Hepatitis C Virus Screening Strategies among Recently Arrived Migrants in the Netherlands
por: Al Khayat, Mohamed N.M.T., et al.
Publicado: (2020)

Effect of breastfeeding promotion interventions on cost-effectiveness of rotavirus immunization in Indonesia
por: Suwantika, Auliya A, et al.
Publicado: (2013)

Antenatal diagnosis of renal tumor: An opportunity lost
por: Sarin, Yogesh K.
Publicado: (2013)

The Metropolitan Asylums Board: Some Lost Opportunities
Publicado: (1904)

COVID-19: Lost opportunities and lessons for the future
por: Saqr, Mohammed, et al.
Publicado: (2020)

MEASURING LOST-WORK OPPORTUNITY AT RETIREMENT AGE
por: Voss, Maren Wright, et al.
Publicado: (2019)

Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines
por: de Boer, Pieter T., et al.
Publicado: (2018)

Lost Work Opportunity Score Predicts Health in Retirement
por: Voss, Maren Wright, et al.
Publicado: (2021)

Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands
por: Westra, Tjalke A, et al.
Publicado: (2013)

Budget and health impact of switching eligible patients with atrial fibrillation to lower- dose dabigatran
por: Fens, Tanja, et al.
Publicado: (2023)

Mortality of Patients Lost to Follow-Up in Antiretroviral Treatment Programmes in Resource-Limited Settings: Systematic Review and Meta-Analysis
por: Brinkhof, Martin W. G., et al.
Publicado: (2009)

Impact of Rotavirus Vaccination on Hospitalisations in Belgium: Comparing Model Predictions with Observed Data
por: Standaert, Baudouin, et al.
Publicado: (2013)

Opportunities lost: Barriers to increasing the use of effective contraception in the Philippines
por: Nagai, Mari, et al.
Publicado: (2019)

Reflections in reproductive medicine 2020: windows of opportunity lost and found
por: Albertini, David F.
Publicado: (2020)

P03: RATIONALE AND DEVELOPMENT OF AN E-HEALTH APPLICATION TO DELIVER PATIENT CENTERED CARE DURING TREATMENT FOR MULTIPLE MYELOMA IN THE NETHERLANDS.
por: Geerts, P, et al.
Publicado: (2022)

The ‘Dynamic’ Marriage Between Varicella and Zoster
por: de Boer, Pieter T., et al.
Publicado: (2015)

Rationale and development of an e-health application to deliver patient-centered care during treatment for recently diagnosed multiple myeloma patients: pilot study of the MM E-coach
por: Geerts, Paul, et al.
Publicado: (2023)

Roll out of intraveneous artesunate under named patient programmes in the Netherlands, Belgium and France
por: Kreeftmeijer-Vegter, Annemarie Rosan, et al.
Publicado: (2013)

COVID-19: An opportunity to vaccinate infants against rotavirus infections
Publicado: (2020)

Cost-effectiveness of a male catch-up human papillomavirus vaccination program in the Netherlands
por: Simons, Joost J.M., et al.
Publicado: (2022)

Quality-Adjusted Life-Years Lost Due to COVID-19 Mortality: Methods and Application for The Netherlands
por: Wouterse, Bram, et al.
Publicado: (2022)

Analyzing generic and branded substitution patterns in the Netherlands using prescription data
por: Pechlivanoglou, Petros, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_jc2ofm09eg7nhr056djdefanu0